Abnormal serum concentrations of proteins in Parkinson's disease.

[1]  Houeto Jean-Luc.  [Parkinson's disease]. , 2022, La Revue du praticien.

[2]  M. Graeber.  Biomarkers for Parkinson's disease , 2009, Experimental Neurology.

[3]  W. Oyen,et al.  FBXO7 mutations cause autosomal recessive, early-onset parkinsonian-pyramidal syndrome , 2009, Neurology.

[4]  R. Krüger.  LRRK2 in Parkinson's disease – drawing the curtain of penetrance: a commentary , 2008, BMC medicine.

[5]  M. Farrer,et al.  Genetic variation of Omi/HtrA2 and Parkinson's disease. , 2008, Parkinsonism & related disorders.

[6]  C. Moskaluk,et al.  Alterations in Barrett's‐related adenocarcinomas: A proteomic approach , 2008, International journal of cancer.

[7]  I. Goldknopf.  Blood-based proteomics for personalized medicine: examples from neurodegenerative disease , 2008, Expert review of proteomics.

[8]  Hyman M. Schipper,et al.  Transcriptional profiling of Alzheimer blood mononuclear cells by microarray , 2007, Neurobiology of Aging.

[9]  I. Goldknopf.  Molecular diagnostics and proteomics on the outskirts of personalized medicine , 2007, Expert review of molecular diagnostics.

[10]  E. Sheta,et al.  Complement C3c and related protein biomarkers in amyotrophic lateral sclerosis and Parkinson's disease. , 2006, Biochemical and biophysical research communications.

[11]  J. Langston,et al.  The parkinson's complex: Parkinsonism is just the tip of the iceberg , 2006, Annals of neurology.

[12]  H. Braak,et al.  Gastric α-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology , 2006, Neuroscience Letters.

[13]  E. Jazin,et al.  Alzheimer's disease: mRNA expression profiles of multiple patients show alterations of genes involved with calcium signaling , 2006, Neurobiology of Disease.

[14]  E. Sinforiani,et al.  Peripheral proteasome and caspase activity in Parkinson disease and Alzheimer disease , 2006, Neurology.

[15]  E. Sheta,et al.  2D gel blood serum biomarkers reveal differential clinical proteomics of the neurodegenerative diseases , 2006, Expert review of proteomics.

[16]  R. Uitti,et al.  Alterations of T-lymphocyte populations in Parkinson disease. , 2005, Parkinsonism & related disorders.

[17]  David A Bennett,et al.  High-resolution serum proteomic profiling of Alzheimer disease samples reveals disease-specific, carrier-protein-bound mass signatures. , 2005, Clinical chemistry.

[18]  R V Jensen,et al.  Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Z. Janka,et al.  Gene expression profile analysis of lymphocytes from Alzheimer's patients , 2005, Psychiatric genetics.

[20]  Thomas Meitinger,et al.  Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology , 2004, Neuron.

[21]  Andrew Lees,et al.  Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease , 2004, Neuron.

[22]  Jie Shen.  Protein Kinases Linked to the Pathogenesis of Parkinson's Disease , 2004, Neuron.

[23]  K. Marder,et al.  Distribution, type, and origin of Parkin mutations: Review and case studies , 2004, Movement disorders : official journal of the Movement Disorder Society.

[24]  S. Lewis,et al.  Biomarkers and Parkinson's disease. , 2004, Brain : a journal of neurology.

[25]  M. Tabaton,et al.  Microarray Analysis in Alzheimer's Disease and Normal Aging , 2004, IUBMB life.

[26]  J. T. Greenamyre,et al.  Parkinson's--Divergent Causes, Convergent Mechanisms , 2004, Science.

[27]  R. Nussbaum,et al.  Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1 , 2004, Science.

[28]  G. Nappi,et al.  Modifications of apoptosis-related protein levels in lymphocytes of patients with Parkinson’s disease. The effect of dopaminergic treatment , 2004, Journal of Neural Transmission.

[29]  W. Markesbery,et al.  Incipient Alzheimer's disease: Microarray correlation analyses reveal major transcriptional and tumor suppressor responses , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[30]  J. Hoenicka,et al.  The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia , 2004, Annals of neurology.

[31]  H. Steinbusch,et al.  Combination of serum markers related to several mechanisms in Alzheimer’s disease , 2003, Neurobiology of Aging.

[32]  B. Oostra,et al.  DJ-1( PARK7), a novel gene for autosomal recessive, early onset parkinsonism , 2003, Neurological Sciences.

[33]  J. Obeso,et al.  How is firing activity of substantia nigra cells regulated? Relevance of pattern‐code in the basal ganglia , 2003, Synapse.

[34]  E. Sheta,et al.  Proteomic Analysis of S-Nitrosylated Proteins in Mesangial Cells * , 2003, Molecular & Cellular Proteomics.

[35]  H. Kuerer,et al.  Identification of distinct protein expression patterns in bilateral matched pair breast ductal fluid specimens from women with unilateral invasive breast carcinoma , 2002, Cancer.

[36]  Y Ben-Shlomo,et al.  How valid is the clinical diagnosis of Parkinson's disease in the community? , 2002, Journal of neurology, neurosurgery, and psychiatry.

[37]  J. Trojanowski,et al.  Parkinson's disease and related synucleinopathies are a new class of nervous system amyloidoses. , 2002, Neurotoxicology.

[38]  E. Bézard,et al.  Structures outside the basal ganglia may compensate for dopamine loss in the presymptomatic stages of Parkinson's disease. , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[39]  J. Jankovic,et al.  The evolution of diagnosis in early Parkinson disease. Parkinson Study Group. , 2000, Archives of neurology.

[40]  J. Langston,et al.  Candidate genes and Parkinson's disease: where to next? , 1999, Neurology.

[41]  A. Lang,et al.  Parkinson's disease. Second of two parts. , 1998, The New England journal of medicine.

[42]  Georg Auburger,et al.  The ubiquitin pathway in Parkinson's disease , 1998, Nature.

[43]  E. Bézard,et al.  Compensatory mechanisms in experimental and human Parkinsonism: towards a dynamic approach , 1998, Progress in Neurobiology.

[44]  S. Minoshima,et al.  Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism , 1998, Nature.

[45]  Olaf Riess,et al.  AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease , 1998, Nature Genetics.

[46]  Robert L. Nussbaum,et al.  Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .

[47]  L A Beckett,et al.  Prevalence of parkinsonian signs and associated mortality in a community population of older people. , 1996, The New England journal of medicine.

[48]  R. Heilig,et al.  The NACP/synuclein gene: chromosomal assignment and screening for alterations in Alzheimer disease. , 1995, Genomics.

[49]  H. Mori,et al.  Tissue-dependent alternative splicing of mRNA for NACP, the precursor of non-A beta component of Alzheimer's disease amyloid. , 1994, Biochemical and biophysical research communications.

[50]  H. Busch,et al.  Presence of protein A24 in rat liver nucleosomes. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[51]  N G Anderson,et al.  High resolution two-dimensional electrophoresis of human plasma proteins. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[52]  H. Busch,et al.  Isopeptide linkage between nonhistone and histone 2A polypeptides of chromosomal conjugate-protein A24. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[53]  M. Olson,et al.  The NH2- and COOH-terminal amino acid sequence of nuclear protein A24. , 1976, The Journal of biological chemistry.

[54]  R. Baum,et al.  Isolation and characterization of protein A24, a "histone-like" non-histone chromosomal protein. , 1975, The Journal of biological chemistry.

[55]  J. Klose.  Protein mapping by combined isoelectric focusing and electrophoresis of mouse tissues , 1975, Humangenetik.

[56]  H. Busch,et al.  Remarkable similarities of peptide fingerprints of histone 2A and nonhistone chromosomal protein A24. , 1975, Biochemical and biophysical research communications.

[57]  P. O’Farrell.  High resolution two-dimensional electrophoresis of proteins. , 1975, The Journal of biological chemistry.

[58]  K. Jellinger,et al.  Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. , 1973, Journal of the neurological sciences.

[59]  M. Olson,et al.  Comparison of nucleolar proteins of normal rat liver and Novikoff hepatoma ascites cells by two-dimensional polyacrylamide gel electrophoresis. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[60]  J. MARGOLIS,et al.  Two-dimensional Resolution of Plasma Proteins by Combination of Polyacrylamide Disc and Gradient Gel Electrophoresis , 1969, Nature.

[61]  M. Hoehn,et al.  Parkinsonism , 1967, Neurology.

[62]  H. Braak,et al.  Parkinson's disease: premotor clinico-pathological correlations. , 2006, Journal of neural transmission. Supplementum.

[63]  Yan Liu,et al.  Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders. , 2006, Journal of Alzheimer's disease : JAD.

[64]  Shalini Jha,et al.  The diagnosis of Parkinson's disease. , 2003, Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology.

[65]  M G Spillantini,et al.  Alpha-synuclein in Lewy bodies. , 1997, Nature.

[66]  S E Ide,et al.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. , 1997, Science.

[67]  S. Fahn.  Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale , 1987 .

[68]  C. Marsden,et al.  Recent Developments in Parkinson's Disease , 1986 .

[69]  J Margolis,et al.  2-dimensional resolution of plasma proteins by combination of polyacrylamide disc and gradient gel electrophoresis. , 1969, Nature.